Article Details
Retrieved on: 2018-04-22 15:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors raised its stake in shares of Bioline RX by 227.3% in the first quarter. <b>Benchmark Capital</b> Advisors now owns 144,000 shares of the biotechnology company's stock worth $138,000 after buying an additional 100,000 shares in the last quarter. KCG Holdings Inc. raised its stake ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here